Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ArthroCare has announced results from its five-year study evaluating the effectiveness of the Topaz MicroDebrider to treat common tendon disorders, and concluded that the patients who had the minimally invasive procedure were highly satisfied with the procedure and continue to experience pain relief.
Subscribe to our email newsletter
The study evaluated the outcome of 82 patients treated for chronic tendinosis using the Topaz MicroDebrider. Assessment of pain relief was monitored over a period of one to five years for each patient and 95% of patients reported good to excellent results. All patients had symptoms of intractable medial and lateral epicondylitis where conservative treatment had previously failed. Patients reported early pain relief, an early return to activity and rapid return of grip strength.
The Topaz MicroDebrider is a wand-like device about the diameter of a pencil tip. Through a small incision, generally an inch in length, the physician applies the device to the problem tendon for multiple 500 millisecond intervals of treatment.
Jack Giroux, president of ArthroCare Sports Medicine, said: “While this particular study focused on the most common tendon-related complaint, Topaz is designed to treat most tendons throughout the body.”